Literature DB >> 26252135

What does the current biotech stock market value?

Laura McNamee1, Fred Ledley1.   

Abstract

Mesh：

Year:  2015        PMID： 26252135     DOI： 10.1038/nbt.3303

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

1.  Making the biotech IPO work.

Authors:  Laura McNamee; Fred Ledley
Journal:  Nat Biotechnol       Date:  2013-11       Impact factor: 54.908

2.  Beyond the biotech IPO: a brave new world.

Authors:  Bruce L Booth
Journal:  Nat Biotechnol       Date:  2009-08       Impact factor: 54.908

Review 3.  Trends in risks associated with new drug development: success rates for investigational drugs.

Authors:  J A DiMasi; L Feldman; A Seckler; A Wilson
Journal:  Clin Pharmacol Ther       Date:  2010-02-03       Impact factor: 6.875

4.  Translational science by public biotechnology companies in the IPO "class of 2000": the impact of technological maturity.

Authors:  Laura McNamee; Fred Ledley
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.